A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio Slams Corporate Interests For Gutting CHIPS Protection, Research Safeguards
America’s law enforcement and intelligence agencies have repeatedly warned lawmakers about the vast threat of Chinese Communist Party espionage and theft. Despite those warnings, the $280 billion CHIPS Act of 2022 lacks critical guardrails to protect American research and development.
In fact, the current version is even weaker than the previous Senate-passed bill because Senate Democrats removed important safeguards.
- “We need to support American production of semiconductors, but we need to do it in a way that benefits our country and our workers. Corporate interests stripped meaningful safeguards from this package and blocked consideration of others.
- “No one should be surprised when we hear stories of Beijing stealing U.S. technology funded by this bill or companies producing more chips in China even as they receive money from the taxpayers.” — U.S. Senator Marco Rubio (R-FL)
Rubio previously introduced three amendments to address critical errors and omissions in the package, including an amendment to require the Department of Commerce to secure congressional approval before altering the definition of “legacy chips.”
Because Senate Democrats blocked all amendments, the Biden Administration will now have the authority to allow CHIPS funding recipients to expand higher-tech chip production in China.
In May 2021, every Senate Democrat voted to kill Rubio’s amendment to create a counterintelligence screening process to protect America’s research and development efforts.